AAAAAA
Results:
1-20
|
Results: 20
Authors:
Bax, R
Bywater, R
Cornaglia, G
Goossens, H
Hunter, P
Isham, V
Jarlier, V
Jones, R
Phillips, I
Sahm, D
Senn, S
Struelens, M
Taylor, D
White, A
Citation: R. Bax et al., Surveillance of antimicrobial resistance - what, how and whither?, CL MICRO IN, 7(6), 2001, pp. 316-325
Authors:
Senn, S
Citation: S. Senn, Drug development means economics in the end, BR MED J, 322(7287), 2001, pp. 675-675
Authors:
Senn, S
Citation: S. Senn, Statistical issues in bioequivalance, STAT MED, 20(17-18), 2001, pp. 2785-2799
Authors:
Senn, S
Citation: S. Senn, Statistical issues in clinical trials in neurology, CLINICAL TRIALS IN NEUROLOGY, 2001, pp. 95-103
Authors:
Colquhoun, D
Senn, S
Citation: D. Colquhoun et S. Senn, Untitled, ANN ALLER A, 84(6), 2000, pp. 639-639
Authors:
Senn, S
Citation: S. Senn, Meta-analysis of increased inhaled steroid or addition of salmeterol in asthma - Researchers can learn from industry based reporting standards, BR MED J, 321(7267), 2000, pp. 1016-1017
Authors:
Senn, S
Citation: S. Senn, The quality of systematic reviews - Review is biased, BR MED J, 321(7256), 2000, pp. 297-297
Authors:
Senn, S
Stevens, L
Chaturvedi, N
Citation: S. Senn et al., Repeated measures in clinical trials: simple strategies for analysis usingsummary measures, STAT MED, 19(6), 2000, pp. 861-877
Authors:
Senn, S
Citation: S. Senn, Letter to the editor, CONTR CL TR, 21(6), 2000, pp. 589-592
Authors:
Cates, C
Senn, S
Citation: C. Cates et S. Senn, Screening mammography re-evaluated, LANCET, 355(9205), 2000, pp. 750-750
Authors:
Senn, S
Ezzet, F
Citation: S. Senn et F. Ezzet, Clinical cross-over trials in phase I, STAT ME M R, 8(3), 1999, pp. 263-278
Authors:
Scherrer, B
Senn, S
Citation: B. Scherrer et S. Senn, Statistical methods in biopharmacy - Preface, STAT MED, 18(14), 1999, pp. 1739-1739
Authors:
Senn, S
Atkinson, A
Whitehead, J
Citation: S. Senn et al., Optimum biased-coin designs for sequential treatment allocation with covariate information - Discussion, STAT MED, 18(14), 1999, pp. 1753-1755
Authors:
Senn, S
Dunne, A
Clayton, D
Citation: S. Senn et al., A new approach to modelling the relationship between in vitro and in vivo drug dissolution/absorption - Discussion, STAT MED, 18(14), 1999, pp. 1877-1877
Authors:
Senn, S
Penny, K
Citation: S. Senn et K. Penny, Multivariate outlier detection applied to multiply imputed laboratory data- Discussion, STAT MED, 18(14), 1999, pp. 1897-1897
Authors:
van Houwelingen, H
Senn, S
Citation: H. Van Houwelingen et S. Senn, Investigating underlying risk as a source of heterogeneity in meta-analysis by S. G. Thompson, T. C. Smith and S. J. Sharp, Statistics in Medicine, 16, 2741-2758 (1997), STAT MED, 18(1), 1999, pp. 110-113
Authors:
Senn, S
Citation: S. Senn, Should the declaration of Helsinki be revised?, N ENG J MED, 341(24), 1999, pp. 1852-1852
Authors:
Senn, S
Grieve, AP
Citation: S. Senn et Ap. Grieve, A comment on optimal allocations for bioequivalence studies, BIOMETRICS, 55(4), 1999, pp. 1314-1315
Authors:
Senn, S
Harrell, FE
Citation: S. Senn et Fe. Harrell, On subgroups and groping for significance, J CLIN EPID, 51(12), 1998, pp. 1367-1367
Authors:
Senn, S
Lambrou, D
Citation: S. Senn et D. Lambrou, Robust and realistic approaches to carry-over, STAT MED, 17(24), 1998, pp. 2849-2864
Risultati:
1-20
|